BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18837769)

  • 1. Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report.
    Tarwater K; Misra S; Misra M
    Hemodial Int; 2008 Oct; 12 Suppl 2():S38-42. PubMed ID: 18837769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.
    Shieh S; Cohen JL; Lim HW
    J Am Acad Dermatol; 2000 Apr; 42(4):645-52. PubMed ID: 10727312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory blisters in porphyria cutanea tarda with topical pimecrolimus combined with oral hydroxychloroquine: an alternative to phlebotomy in patients with renal insufficiency and anemia.
    Chou TC; Su YS; Wu SM; Wang CC; Lee CH
    Eur J Dermatol; 2012; 22(4):567-8. PubMed ID: 22735193
    [No Abstract]   [Full Text] [Related]  

  • 4. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porphyria cutanea tarda occurring in a patient with renal failure, systemic lupus erythematosus and chronic hepatitis C infection treated with hemodialysis.
    Lee PK; Abrahams I; Bickers DR
    Cutis; 1999 Oct; 64(4):237-9. PubMed ID: 10544877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine].
    Pitche P; Corrin E; Wolkenstein P; Revuz J; Bagot M
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):37-9. PubMed ID: 12605155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyria cutanea tarda in a chronic hemodialysis patient.
    Labidi J
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):919-22. PubMed ID: 20814132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Porphyria cutanea tarda, chronic liver disease caused by the C virus and hepatocarcinoma. Clinical case].
    Armas R; Krause P; Wolff C
    Rev Med Chil; 1994 Jan; 122(1):72-4. PubMed ID: 7915041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between porphyria cutanea tarda and beta-thalassemia major.
    Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda in a dialyzed patient with hepatitis C virus infection: dramatic efficacy of small repeated phlebotomies.
    Poux JM; Demontis R; Cadranel JF; Ghazali A; Fievet P; Nordmann Y
    Am J Med; 1997 Aug; 103(2):163-4. PubMed ID: 9274900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sclerodermatous changes in porphyria cutanea tarda: six cases].
    Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F
    Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Porphyria cutanea tarda and hepatitis C virus infection].
    Held E; Petersen CS
    Ugeskr Laeger; 1997 Feb; 159(9):1284-6. PubMed ID: 9072876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda associated with chronic renal disease and hemodialysis.
    Poh-Fitzpatrick MB; Masullo AS; Grossman ME
    Arch Dermatol; 1980 Feb; 116(2):191-5. PubMed ID: 7356350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infection with hepatitis C virus in porphyria cutanea tarda].
    Lima J; Serejo F; Gloria H; Ramalho F; Moura MC
    Acta Med Port; 1996; 9(7-9):283-6. PubMed ID: 9005712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda in the setting of renal failure. Response to renal transplantation.
    Stevens BR; Fleischer AB; Piering F; Crosby DL
    Arch Dermatol; 1993 Mar; 129(3):337-9. PubMed ID: 8095384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
    Chan OT; Tsai N; Wong RL; Izumi AK
    Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus infection in patients with porphyria].
    Wolff C; Armas R; Puig A; Krause P; Parraguez A
    Rev Med Chil; 1994 Mar; 122(3):294-8. PubMed ID: 7528936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda.
    Sunkara B; Roofeh D; Silver S; Pearson TL; Ettel M; McCune WJ
    Lupus; 2018 Jul; 27(8):1383-1386. PubMed ID: 29631513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure.
    Vasconcelos P; Luz-Rodrigues H; Santos C; Filipe P
    Dermatol Ther; 2014; 27(1):16-8. PubMed ID: 24502304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.